Archives
-
Phosbind Biotin LC Western Blot Guide
2026-08-21
Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes when phospho-specific antibodies are unavailable or too narrowly targeted. It is intended for fresh, solvent-compatible Western Blot workflows with streptavidin-HRP and chemiluminescence, not aqueous-only protocols or long-term storage of prepared solutions.
-
H-Aggregated IR-1061 for NIR-II Cancer Therapy
2026-08-20
Yu et al. developed an RR9-functionalized anionic liposome that co-delivers IR-1061 and carboplatin while transferring the dye’s H-aggregated state to tumor cell membranes. The resulting platform integrates NIR-II fluorescence imaging with NIR-I photothermal therapy and temperature-responsive chemotherapy, offering a mechanistic strategy for improving image-guided cancer treatment.
-
EVMPs for Extrahepatic mRNA Delivery
2026-08-20
The reference study introduces a bottom-up, self-assembling enveloped virus-mimicking particle (EVMP) designed to overcome the hepatic bias of many mRNA delivery systems. By combining an engineered virus-mimicking peptide with tunable phospholipid envelopes, the authors achieved substantial lung delivery, therapeutic activity with IL-12 mRNA, and evidence supporting repeat administration.
-
GluN2A/2B–Connexin Signaling in TMJ Pain
2026-08-19
The reference study identifies distinct roles for the NMDAR subunits GluN2A and GluN2B in trigeminal ganglion sensitization during temporomandibular joint inflammation. Using conditional genetics, behavioral testing, satellite glial cell models, and pathway analysis, it connects NMDAR activity with connexin- and pannexin-mediated intercellular communication, particularly through ERK1/2 and related signaling pathways.
-
PDGF-BB for Pulmonary Vascular Remodeling Research
2026-08-19
Use murine recombinant PDGF-BB as a defined mitogenic control for smooth muscle cell proliferation, receptor-response profiling, and pulmonary hypertension workflows. Its documented BALB/c 3T3 potency and low endotoxin specification make it useful for separating growth-factor effects from hypoxia- and metabolism-driven phenotypes.
-
RNA Pol II Loss Activates Apoptosis Beyond Transcription
2026-08-18
Harper et al. show that RNA polymerase II inhibition kills cells through an active apoptotic program triggered by loss of hypophosphorylated RNA Pol IIA, rather than through transcriptional failure alone. Their PDAR model clarifies how diverse anticancer compounds can converge on RNA Pol II degradation-dependent mitochondrial death signaling and provides a framework for interpreting mechanistic cell-death assays.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-08-18
Build a more sensitive western blot workflow for scarce targets, from membrane selection and antibody dilution to exposure timing and signal preservation. This guide shows how the hypersensitive ECL Chemiluminescent Substrate Detection Kit can support pathway-level validation in metabolic research while reducing background and conserving antibodies.
-
Trelagliptin, RUNX2, and Osteoblast Differentiation
2026-08-17
The reference study identifies a previously underexplored skeletal action of the DPP-4 inhibitor trelagliptin: enhancement of osteoblastic differentiation and mineralization in MC3T3-E1 cells through an AMPK-associated increase in RUNX2. Its findings provide a mechanistic basis for further investigation of trelagliptin in osteoporosis, while remaining preclinical and dependent on validation in primary cells and in vivo models.
-
D-Luciferin Sodium Salt in CAR-M Translation
2026-08-17
A thought-leadership guide to using D-Luciferin sodium salt as a mechanistically informed reporter substrate in CAR macrophage research, linking ATP-dependent bioluminescence assays with longitudinal oncology studies, mRNA-LNP programming, and translational decision-making.
-
SHC-1 Inhibition and CFTR Surface Abundance
2026-08-16
A 2026 study shows that MAPK/SHC-1-dependent CFTR internalization occurs across several epithelial models, but pharmacological elevation of surface CFTR is strongly cell-type specific. The findings refine how researchers should interpret CFTR trafficking assays and suggest that CFBE cells may overstate the selectivity of SHC-1-directed interventions.
-
Cepharanthine Inhibits Endometriosis Growth Across Models
2026-08-15
A 2026 study evaluated the biscoclaurine alkaloid Cepharanthine across immortalized stromal cells, patient-derived endometriotic cells, endometrial organoids, and a murine peritoneal model. Its data connect growth suppression to DNA damage, impaired repair, G0/G1 arrest, and mitochondrial apoptosis, while also illustrating the value and limits of organoid-to-animal validation.
-
p21–ELP Delivery Suppresses Glioblastoma Proliferation
2026-08-14
Quinn, Shaheen, and Raucher evaluated an elastin-like polypeptide carrier for delivering a p21-derived inhibitory peptide into U87, GBM43, and GBM6 glioblastoma cells. The construct was internalized across all models and primarily suppressed proliferation through cytostatic activity, while apoptosis remained limited and varied by cell line.
-
Firefly Luciferase mRNA: From Signal to Delivery
2026-08-14
Firefly Luciferase mRNA (ARCA, 5-moUTP) is examined as a measurement tool rather than simply a bright reporter. This guide connects RNA chemistry, assay interpretation, and nanoparticle delivery decisions for more defensible gene expression, viability, and imaging results.
-
Hexetidine Mouthwash: Systematic Review Findings
2026-08-13
The Afennich et al. systematic review assessed whether hexetidine mouthwash prevents plaque accumulation and gingival inflammation in adults without periodontitis. Its central finding was that, although Hexetidine has antimicrobial and plaque-control activity, the balance of benefit and adverse effects makes it a poor alternative to chlorhexidine.
-
SlSLAH1 and STOP1-Mediated Malate Exudation in Tomato
2026-08-13
The reference study identifies SlSLAH1 as a plasma-membrane malate transporter that links SlSTOP1–SlSZP1 transcriptional control with SlSLAH1–SlSLAH2 channel-complex activity during aluminium stress. Its genetic, molecular, and physiological evidence clarifies how tomato roots coordinate malate exudation and provides a framework for studying aluminium-tolerance traits.